Literatur
Betschart C, Albrich W, Brandner S, Faltin D, Kuhn A, Surbek D, Geissbühler V (2018) Akute und rezidivierende Harnwegsinfektionen. Expertenbrief No 58. Schweizerische Gesellschaft für Gynäkologie und Geburtshilfe
Grigoryan L, Trautner BW, Gupta K (2014) Diagnosis and management of urinary tract infections in the outpatient setting: a review. JAMA 312(16):1677–1684. https://doi.org/10.1001/jama.2014.12842
Schulz L, Hoffman RJ, Pothof J, Fox B (2016) Top ten myths regarding the diagnosis and treatment of urinary tract infections. J Emerg Med 51(1):25–30.
Bent S, Nallamothu BK, Simel DL, Fihn SD, Saint S (2002) Does this woman have an acute uncomplicated urinary tract infection? JAMA 287(20):2701–2710
Gupta K, Hooton TM, Naber KG, et al., Infectious Diseases Society of America, European Society for Microbiology and Infectious Diseases (2011) International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis 52(5):e103–20. https://doi.org/10.1093/cid/ciq257
Aydin A, Ahmed K, Zaman I, Khan MS, Dasgupta P (2015) Recurrent urinary tract infections in women. Int Urogynecol J 26(6):795–804. https://doi.org/10.1007/s00192-014-2569-5
Perrotta C, Aznar M, Mejia R, Albert X, Ng CW (2008) Oestrogens for preventing recurrent urinary tract infection in postmenopausal women. Cochrane Database Syst Rev 2:CD5131. https://doi.org/10.1002/14651858.CD005131.pub2
Rahn DD, Carberry C, Sanses TV, et al., Society of Gynecologic Surgeons Systematic Review Group (2014) Vaginal estrogen for genitourinary syndrome of menopause: a systematic review. Obstet Gynecol 124(6):1147–1156. https://doi.org/10.1097/AOG.0000000000000526
Altarac S, Papeš D (2014) Use of D‑mannose in prophylaxis of recurrent urinary tract infections (UTIs) in women. BJU Int 113(1):9–10. https://doi.org/10.1111/bju.12492
Kranjčec B, Papeš D, Altarac S (2014) D‑mannose powder for prophylaxis of recurrent urinary tract infections in women: a randomized clinical trial. World J Urol 32(1):79–84. https://doi.org/10.1007/s00345-013-1091-6
Bauer HW, Alloussi S, Egger G, Blümlein HM, Cozma G, Schulman CC, Multicenter UTI Study Group (2005) A long-term, multicenter, double-blind study of an Escherichia coli extract (OM-89) in female patients with recurrent urinary tract infections. Eur Urol 47(4):542–548 (discussion 548)
Krebs J, Fleischli S, Stoyanov J, Pannek J (2019) Effects of oral immunomodulation therapy on urinary tract infections in individuals with chronic spinal cord injury—A retrospective cohort study. Neurourol Urodyn 38(1):346–352.
Siegers C, Bodinet C, Ali SS, Siegers CP (2003) Bacterial deconjugation of arbutin by Escherichia coli. Phytomedicine 10(Suppl 4):58–60
Jepson RG, Williams G, Craig JC (2012) Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev 10:CD1321. https://doi.org/10.1002/14651858.CD001321.pub5
O’Kane DB, Dave SK, Gore N, Patel F, Hoffmann TC, Trill JL, Del Mar CB (2016) Urinary alkalisation for symptomatic uncomplicated urinary tract infection in women. Cochrane Database Syst Rev 4:CD10745.
Albert X, Huertas I, Pereiró II, Sanfélix J, Gosalbes V, Perrota C (2004) Antibiotics for preventing recurrent urinary tract infection in non-pregnant women. Cochrane Database Syst Rev 3:CD1209
Nicolle LE, Bradley S, Colgan R, Rice JC, Schaeffer A, Hooton TM, Infectious Diseases Society of America American Society of Nephrology American Geriatric Society (2005) Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clin Infect Dis 40(5):643–654
National Institute for Health and Care Excellence (NICE) (2015) Urinary tract infections in adults. NICE
Eyer MM, Läng M, Aujesky D, Marschall J (2016) Overtreatment of asymptomatic bacteriuria: a qualitative study. J Hosp Infect 93(3):297–303.
Averbeck MA, Altaweel W, Manu-Marin A, Madersbacher H (2017) Management of LUTS in patients with dementia and associated disorders. Neurourol Urodyn 36(2):245–252. https://doi.org/10.1002/nau.22928
Lin K, Watkins B, Johnson T, Rodriguez JA, Barton MB, U.S. Preventive Services Task Force (2008) Screening for chronic obstructive pulmonary disease using spirometry: summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 148(7):535–543
Shuman EK, Chenoweth CE (2018) Urinary catheter-associated infections. Infect Dis Clin North Am 32(4):885–897. https://doi.org/10.1016/j.idc.2018.07.002
Hooton TM, Bradley SF, Cardenas DD, et al., Infectious Diseases Society of America (2010) Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America. Clin Infect Dis 50(5):625–663
Brubaker L, Wolfe AJ (2015) The new world of the urinary microbiota in women. Am J Obstet Gynecol 213(5):644–649. https://doi.org/10.1016/j.ajog.2015.05.032
Price TK, Hilt EE, Dune TJ, Mueller ER, Wolfe AJ, Brubaker L (2018) Urine trouble: should we think differently about UTI? Int Urogynecol J 29(2):205–210. https://doi.org/10.1007/s00192-017-3528-8
Mueller ER, Wolfe AJ, Brubaker L (2017) Female urinary microbiota. Curr Opin Urol 27(3):282–286.
Schneeweiss J, Koch M, Umek W (2016) The human urinary microbiome and how it relates to urogynecology. Int Urogynecol J 27(9):1307–1312. https://doi.org/10.1007/s00192-016-2944-5
Pearce MM, Zilliox MJ, Rosenfeld AB, et al., Pelvic Floor Disorders Network (2015) The female urinary microbiome in urgency urinary incontinence. Am J Obstet Gynecol 213(3):347.e1–347.11. https://doi.org/10.1016/j.ajog.2015.07.009
McDonald M, Kameh D, Johnson ME, Johansen TEB, Albala D, Mouraviev V (2017) A head-to-head comparative phase II study of standard urine culture and sensitivity versus DNA next-generation sequencing testing for urinary tract infections. Rev Urol 19(4):213–220. https://doi.org/10.3909/riu0780
Goddard JC, Janssen DAW (2018) Intravesical hyaluronic acid and chondroitin sulfate for recurrent urinary tract infections: systematic review and meta-analysis. Int Urogynecol J 29(7):933–942. https://doi.org/10.1007/s00192-017-3508-z
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
S. Mohr gibt an, dass kein Interessenkonflikt besteht.
Additional information
Hinweis des Verlags
Der Verlag bleibt in Hinblick auf geografische Zuordnungen und Gebietsbezeichnungen in veröffentlichten Karten und Institutsadressen neutral.
Rights and permissions
About this article
Cite this article
Mohr, S. Und nun noch schnell – HWI aktuell. J. Gynäkol. Endokrinol. CH 22, 128–132 (2019). https://doi.org/10.1007/s41975-019-00106-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s41975-019-00106-2